General Information of Drug (ID: DMP9A7L)

Drug Name
N-(1-Benzyl-2-oxo-ethyl)-benzamide
Synonyms
CHEMBL287136; N-(1-Benzyl-2-oxo-ethyl)-benzamide; N-Benzoyl-L-phenylalaninal; benzamide, n-[(1s)-1-formyl-2-phenylethyl]-; AC1L4VU2; SCHEMBL40781; AC1Q6A59; ZINC3650451; BDBM50014566; N-[(2S)-1-oxo-3-phenylpropan-2-yl]benzamide; (2S)-2-(Benzoylamino)-3-phenylpropionaldehyde; Benzamide, N-(1-formyl-2-phenylethyl)-, (S)-
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 253.29
Topological Polar Surface Area (xlogp) 2.7
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C16H15NO2
IUPAC Name
N-[(2S)-1-oxo-3-phenylpropan-2-yl]benzamide
Canonical SMILES
C1=CC=C(C=C1)C[C@@H](C=O)NC(=O)C2=CC=CC=C2
InChI
InChI=1S/C16H15NO2/c18-12-15(11-13-7-3-1-4-8-13)17-16(19)14-9-5-2-6-10-14/h1-10,12,15H,11H2,(H,17,19)/t15-/m0/s1
InChIKey
HIVDFHSZNYCJQH-HNNXBMFYSA-N
Cross-matching ID
PubChem CID
193218
CAS Number
35593-57-8
TTD ID
D00JPH

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calpain-2 (CAPN2) TTG5QB7 CAN2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Calpain-2 (CAPN2) DTT CAPN2 5.15E-14 0.35 1.04
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Alpha-diketone and alpha-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinases. J Med Chem. 1990 Jan;33(1):11-3.
2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
3 An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31.